Dry Age-related Macular Degeneration KOL Symposium

Dr. Mary Hamby, Cognition’s vice president of research reviewed preclinical data supporting the Company’s plans to advance a small molecule sigma-2 (σ-2) modulator into Phase 2 clinical studies for the treatment of dry age-related macular degeneration (dry AMD)
Dr. Karl Csaky, CMO of the Retina Foundation of the Southwest provided an overview of dry AMD pathology, disease drivers and patient burden
Dr. Stella Robertson, founder of Arrochar Consulting led a panel of scientific and clinical experts including Dr. Csaky, Dr. Jennifer Lim from University of Illinois, and Dr. Arjuna Ratnayaka from the University of Southampton in a discussion of experimental approaches and the current dry AMD treatment landscape
Lisa Ricciardi, Cognition’s president and CEO moderated a live Q&A

Event Details